TLT-1-CONTROLS EARLY THROMBUS FORMATION AND STABILITY BY FACILITATING AIIBB3 OUTSIDE-IN SIGNALING IN MICE

Area of Science:

• Immunology
• Hematology
• Vascular Biology

Background:

• Platelets play a key role in both hemostasis and inflammation.
• The precise mechanisms by which inflammatory insults trigger hemostatic function are not fully understood.
• Triggering receptor expressed in myeloid cells (TREM)-like transcript 1 (TLT-1) is a platelet receptor implicated in inflammatory responses.

Purpose of the Study:

• To investigate the role of TLT-1 in immune-mediated bleeding.
• To elucidate the mechanisms by which TLT-1 influences clot formation and vascular integrity during inflammation.

Main Methods:

• Utilized cremaster muscle inflammation models in wild-type and TLT-1 deficient mice.
• Employed whole-mount immunofluorescence staining to assess clot size and plasma extravasation.
• Analyzed integrin β3 phosphorylation and platelet outside-in signaling.
• Investigated TLT-1's role in reverse Arthus reaction and pulmonary embolism models.

Main Results:

• TLT-1 deficiency resulted in a 50% reduction in clot size and increased plasma extravasation in inflamed cremaster muscle.
• Absence of TLT-1 led to a twofold reduction in integrin β3 phosphorylation at Y773 upon platelet activation.
• TLT-1 deficient mice exhibited impaired platelet outside-in signaling and smaller thrombi formation.
• TLT-1 was shown to regulate thrombosis in various experimental models.

Conclusions:

• TLT-1 is essential for stabilizing αIIbβ3 outside-in signaling, thereby regulating early clot formation.
• TLT-1 plays a significant role in controlling immune-derived bleeding and thrombosis.
• Targeting TLT-1 may offer therapeutic potential for managing inflammatory bleeding disorders.